These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4190461)

  • 1. [Hormone treatment of benign prostatic hypertrophy].
    Sember M; Bernstein-Hahn L
    Rev Argent Urol Nefrol; 1969 Sep; 38(9):160-1. PubMed ID: 4190461
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonoperative management of senile prostatic hyperplasia.
    Fam A
    Int Surg; 1971 Oct; 56(4):252-9. PubMed ID: 4106484
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of male & female hormones combined in depot doses in treatment of prostatic hypertrophy].
    XIUME GB; MOLINO N
    Minerva Med; 1958 Jun; 49(47):2370-3. PubMed ID: 13565670
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined hormonal treatment in hypertrophy of the prostate.
    MONTICONE C
    Minerva Med; 1958 Jun; 49(47):2374-5. PubMed ID: 13565671
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of benign prostatic hyperplasia with the preparation Gentos].
    Pecherskiĭ AV; Aleksandrov VP; Mazurov VI; Kniaz'kin IV; Zeziulin PN; Nikolaeva EV
    Urologiia; 2000; (5):16-7. PubMed ID: 11392216
    [No Abstract]   [Full Text] [Related]  

  • 6. [The influence of spironolactone on the concentration of gonadotrophins and gonadal hormones in prostatic hypertrophy (author's transl)].
    Zgliczynski S; Baranowska B; Szymanowski J
    J Urol (Paris); 1981; 87(9):635-8. PubMed ID: 6174646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative treatment of benign prostatic hypertrophy.
    Brosig W
    Prog Clin Biol Res; 1976; 6():91-4. PubMed ID: 66699
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pre- and post-prostatectomy variation and supplement of sexual hormones in patients with benign prostatic hyperplasia].
    Ren XM; Ying J; Yao DH; Jiang YQ; Xu MX
    Zhonghua Nan Ke Xue; 2005 Jan; 11(1):50-2, 55. PubMed ID: 15704683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of antiestrogen, antiandrogen, and the prolactin inhibitor 2 bromo-alpha-ergocriptine on the stromal tissue of human benign prostatic hyperplasia. Correlation of stereological data and plasma hormones.
    Bartsch G; Oberholzer M; Rohr HP
    Invest Urol; 1981 Jan; 18(4):308-12. PubMed ID: 6161105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormonal therapy of benign prostatic hyperplasia].
    Horninger W; Bartsch G
    Urologe A; 1995 Jan; 34(1):9-15. PubMed ID: 7533450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the causal genesis of prostatic hypertrophy. II].
    Kaufmann J
    Z Urol Nephrol; 1968 Apr; 61(4):229-50. PubMed ID: 4172338
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical management of benign prostatic hypertrophy.
    Geller J
    Compr Ther; 1994; 20(12):682-7. PubMed ID: 7533690
    [No Abstract]   [Full Text] [Related]  

  • 13. Testosterone levels in benign prostatic hypertrophy and prostate cancer.
    Mearini L; Costantini E; Zucchi A; Mearini E; Bini V; Cottini E; Porena M
    Urol Int; 2008; 80(2):134-40. PubMed ID: 18362481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The action of different forms of hormone therapy in prostatic adenoma].
    Délivéliotis A; Rodis N
    J Urol Nephrol (Paris); 1968 Mar; 74(3):211-22. PubMed ID: 4171642
    [No Abstract]   [Full Text] [Related]  

  • 15. [Androgen deprivation in benign prostatic hypertrophy].
    Tenaglia R; Nicolai M; Di Federico G; Iantorno R; Zezza A; Lombardi G
    J Urol (Paris); 1993; 99(6):296-8. PubMed ID: 7516371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacotherapy in benign prostatic hyperplasia].
    Hauri D
    Ther Umsch; 1995 Jun; 52(6):378-82. PubMed ID: 7541566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Doxazosin in the treatment of benign prostatic hypertrophy].
    Rollema HJ; Janknegt RA
    J Urol (Paris); 1993; 99(6):314-5. PubMed ID: 7516377
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mepartricin as medical treatment of benign prostatic hypertrophy].
    Micali F; Giurioli A; Virgili G; Vespasiani G
    J Urol (Paris); 1993; 99(6):293-5. PubMed ID: 7516370
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adrenal androgens and circulating 17 beta-estradiol/testosterone ratio in benign hyperplasia of the prostate].
    Corrales Hernández JJ; García Díez LC; Martín Rodríguez M; Montero Gómez J; Miralles García JM
    Med Clin (Barc); 1984 May; 82(17):751-3. PubMed ID: 6204173
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug treatment options in prostatic hyperplasia].
    Hauri D
    Praxis (Bern 1994); 1997 Sep; 86(38):1463-6. PubMed ID: 9381047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.